Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) EPS (Basic) (2023 - 2025)

Historic EPS (Basic) for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to $0.36.

  • Rallybio's EPS (Basic) rose 23846.15% to $0.36 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.32, marking a year-over-year increase of 7987.42%. This contributed to the annual value of -$1.28 for FY2024, which is 3068.61% up from last year.
  • Latest data reveals that Rallybio reported EPS (Basic) of $0.36 as of Q3 2025, which was up 23846.15% from -$0.22 recorded in Q2 2025.
  • In the past 5 years, Rallybio's EPS (Basic) registered a high of $0.36 during Q3 2025, and its lowest value of -$0.49 during Q4 2023.
  • Its 3-year average for EPS (Basic) is -$0.29, with a median of -$0.37 in 2024.
  • Per our database at Business Quant, Rallybio's EPS (Basic) plummeted by 930.23% in 2024 and then skyrocketed by 23846.15% in 2025.
  • Quarter analysis of 3 years shows Rallybio's EPS (Basic) stood at -$0.49 in 2023, then skyrocketed by 50.26% to -$0.24 in 2024, then soared by 247.69% to $0.36 in 2025.
  • Its EPS (Basic) was $0.36 in Q3 2025, compared to -$0.22 in Q2 2025 and -$0.21 in Q1 2025.